1. Impact of Antiviral Therapy on Risk of Hepatocellular Carcinoma

   • Vincent Wai-Sun Wong
   • Joseph Jao-Yiu Sung

   ReviewPaper 13 April 2010 Pages: 47 - 52

2. Baseline and On-Treatment Predictors for Outcome of Chronic Hepatitis B Treatment

   • Johannes Vermehren
   • Annika Kau
   • Stefan Zeuzem

   ReviewPaper 14 April 2010 Pages: 53 - 59

3. Immune-Tolerant Hepatitis B Infection: To Treat or Not to Treat?

   • Matthew J. Giefer
   • Karen F. Murray

   ReviewPaper 30 March 2010 Pages: 60 - 64

   

4. Histologic Disease in Patients with Chronic Hepatitis B, High HBV DNA, and Normal Alanine Aminotransferase Levels

   • Joseph K. Lim
   • Walid S. Ayoub
   • Mindie H. Nguyen

   ReviewPaper 29 April 2010 Pages: 65 - 74

5. A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B

   • Vandana Khungar
   • Steven-Huy Han

   ReviewPaper Open access 21 April 2010 Pages: 75 - 90

6. Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B

   • Milan J. Sonneveld
   • Harry L. A. Janssen

   ReviewPaper Open access 15 April 2010 Pages: 91 - 98

7. Hepatitis B and Renal Disease

   • Tak Mao Chan

   ReviewPaper Open access 14 April 2010 Pages: 99 - 105

8. Ethnic and Racial Differences in the Natural History of Hepatitis C

   • Eric R. Kallwitz

   ReviewPaper 13 April 2010 Pages: 106 - 112

9. Management of Psychiatric Disease in Hepatitis C Treatment Candidates

   • Francis Lotrich

   ReviewPaper 06 April 2010 Pages: 113 - 118

10. Treatment of Acute Hepatitis B with Nucleoside and/or Nucleotide Analogues

    • Helen S. Te

    ReviewPaper 30 March 2010 Pages: 119 - 123